Varying virulence: Epigenetic control of expression noise and disease processes

Trends in Biotechnology

Volumn 29, Issue 10, 2011, Pages 517-525

  Miller Jensen, Kathryn ^a,b   Dey, Siddharth S ^c   Schaffer, David V ^b,c,d   Arkin, Adam P ^b,d,e  

^a Yale University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California at Berkeley   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATIN MODIFICATION; CHROMATIN REMODELING; DISEASE PROCESS; DRUG RESISTANCE; EPIGENETIC CONTROL; INTRINSIC NOISE; PHENOTYPIC DIVERSITY; RANDOM TRANSITION; THERAPEUTIC INTERVENTION; VIRAL INFECTIONS;

CHROMOSOMES; DISEASE CONTROL;

GENE EXPRESSION;

DNA; INTERLEUKIN 4; MICRORNA; TUMOR NECROSIS FACTOR ALPHA;

CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA BINDING; DROSOPHILA MELANOGASTER; EPIGENETICS; EUKARYOTE; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NEOPLASM; NOISE; NONHUMAN; NUCLEOSOME; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; VIRULENCE; VIRUS INFECTION;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPUTATIONAL BIOLOGY; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PHENOTYPE; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EUKARYOTA;

EID: 80052809114     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2011.05.004     Document Type: Review

References (80)

1. McAdams H.H., Arkin A. Stochastic mechanisms in gene expression. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:814-819.
2. Eldar A., Elowitz M.B. Functional roles for noise in genetic circuits. Nature 2010, 467:167-173.
3. Losick R., Desplan C. Stochasticity and cell fate. Science 2008, 320:65-68.
4. Acar M., et al. Stochastic switching as a survival strategy in fluctuating environments. Nat. Genet. 2008, 40:471-475.
5. Wolf D.M., et al. A microbial modified prisoner's dilemma game: how frequency-dependent selection can lead to random phase variation. J. Theor. Biol. 2005, 234:255-262.
6. Lidstrom M.E., Konopka M.C. The role of physiological heterogeneity in microbial population behavior. Nat. Chem. Biol. 2010, 6:705-712.
7. Balaban N.Q., et al. Bacterial persistence as a phenotypic switch. Science 2004, 305:1622-1625.
8. Lewis K. Persister cells. Annu. Rev. Microbiol. 2010, 64:357-372.
9. Gefen O., Balaban N.Q. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol. Rev. 2009, 33:704-717.
10. Singh A., Weinberger L.S. Stochastic gene expression as a molecular switch for viral latency. Curr. Opin. Microbiol. 2009, 12:460-466.
11. Stumpf M.P., et al. Herpes viruses hedge their bets. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15234-15237.
12. Niepel M., et al. Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr. Opin. Chem. Biol. 2009, 13:556-561.
13. Raj A., van Oudenaarden A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 2008, 135:216-226.
14. Thattai M., van Oudenaarden A. Intrinsic noise in gene regulatory networks. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8614-8619.
15. Newman J.R., et al. Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature 2006, 441:840-846.
16. Raj A., et al. Stochastic mRNA synthesis in mammalian cells. PLoS Biol. 2006, 4:e309.
17. Zenklusen D., et al. Single-RNA counting reveals alternative modes of gene expression in yeast. Nat. Struct. Mol. Biol. 2008, 15:1263-1271.
18. Skupsky R., et al. HIV promoter integration site primarily modulates transcriptional burst size rather than frequency. PLoS Comput. Biol. 2010, 6:e1000592.
19. Sigal A., et al. Variability and memory of protein levels in human cells. Nature 2006, 444:643-646.
20. Cohen A.A., et al. Protein dynamics in individual human cells: experiment and theory. PLoS ONE 2009, 4:e4901.
21. Segal E., Widom J. From DNA sequence to transcriptional behaviour: a quantitative approach. Nat. Rev. Genet. 2009, 10:443-456.
22. Mao C., et al. Occlusion of regulatory sequences by promoter nucleosomes in vivo. PLoS ONE 2011, 6:e17521.
23. Kundu S., Peterson C.L. Role of chromatin states in transcriptional memory. Biochim. Biophys. Acta 2009, 1790:445-455.
24. Becskei A., et al. Contributions of low molecule number and chromosomal positioning to stochastic gene expression. Nat. Genet. 2005, 37:937-944.
25. Tirosh I., Barkai N. Two strategies for gene regulation by promoter nucleosomes. Genome Res. 2008, 18:1084-1091.
26. Choi J.K., Kim Y.J. Epigenetic regulation and the variability of gene expression. Nat. Genet. 2008, 40:141-147.
27. Field Y., et al. Distinct modes of regulation by chromatin encoded through nucleosome positioning signals. PLoS Comput. Biol. 2008, 4:e1000216.
28. Boeger H., et al. Nucleosome retention and the stochastic nature of promoter chromatin remodeling for transcription. Cell 2008, 133:716-726.
29. Mao C., et al. Quantitative analysis of the transcription control mechanism. Mol. Syst. Biol. 2010, 6:431.
30. Bai L., et al. Nucleosome-depleted regions in cell-cycle-regulated promoters ensure reliable gene expression in every cell cycle. Dev. Cell 2010, 18:544-555.
31. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
32. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat. Rev. Genet. 2008, 9:15-26.
33. Ahmad K., Henikoff S. Modulation of a transcription factor counteracts heterochromatic gene silencing in Drosophila. Cell 2001, 104:839-847.
34. Rando O.J., Verstrepen K.J. Timescales of genetic and epigenetic inheritance. Cell 2007, 128:655-668.
35. Muramoto T., et al. Methylation of H3K4 is required for inheritance of active transcriptional states. Curr. Biol. 2010, 20:397-406.
36. Mariani L., et al. Short-term memory in gene induction reveals the regulatory principle behind stochastic IL-4 expression. Mol. Syst. Biol. 2010, 6:359.
37. Han Y., et al. Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 2007, 5:95-106.
38. Joos B., et al. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16725-16730.
39. Richman D.D., et al. The challenge of finding a cure for HIV infection. Science 2009, 323:1304-1307.
40. Weinberger L.S., et al. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005, 122:169-182.
41. Weinberger L.S., et al. Transient-mediated fate determination in a transcriptional circuit of HIV. Nat. Genet. 2008, 40:466-470.
42. Blazkova J., et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 2009, 5:e1000554.
43. Margolis D.M. Mechanisms of HIV latency: an emerging picture of complexity. Curr. HIV/AIDS Rep. 2010, 7:37-43.
44. Singh A., et al. Transcriptional bursting from the HIV-1 promoter is a significant source of stochastic noise in HIV-1 gene expression. Biophys. J. 2010, 98:L32-34.
45. Jordan A., et al. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 2001, 20:1726-1738.
46. Sadowski I., et al. Factors controlling chromatin organization and nucleosome positioning for establishment and maintenance of HIV latency. Curr. HIV Res. 2008, 6:286-295.
47. Burnett J.C., et al. Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog. 2009, 5:e1000260.
48. Speck S.H., Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 2010, 8:100-115.
49. Knipe D.M., Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 2008, 6:211-221.
50. Thompson R.L., et al. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog. 2009, 5:e1000352.
51. Grzimek N.K., et al. Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J. Virol. 2001, 75:2692-2705.
52. Gunther T., Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 2010, 6:e1000935.
53. Toth Z., et al. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 2010, 6:e1001013.
54. Bellare P., Ganem D. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 2009, 6:570-575.
55. Johnson V.A., et al. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med. 2010, 18:156-163.
56. Burnett J.C., et al. Combinatorial latency reactivation for HIV-1 subtypes and variants. J. Virol. 2010, 84:5958-5974.
57. Kauder S.E., et al. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 2009, 5:e1000495.
58. Lehrman G., et al. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 2005, 366:549-555.
59. Weinberger L.S., et al. Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J. Virol. 2003, 77:10028-10036.
60. Cohen A.A., et al. Dynamic proteomics of individual cancer cells in response to a drug. Science 2008, 322:1511-1516.
61. Spencer S.L., et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459:428-432.
62. Singh D.K., et al. Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities. Mol. Syst. Biol. 2010, 6:369.
63. Sharma S.V., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
64. Roesch A., et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141:583-594.
65. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
66. Chang H.H., et al. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008, 453:544-547.
67. Elowitz M.B., et al. Stochastic gene expression in a single cell. Science 2002, 297:1183-1186.
68. Raser J.M., O'Shea E.K. Control of stochasticity in eukaryotic gene expression. Science 2004, 304:1811-1814.
69. Huh D., Paulsson J. Non-genetic heterogeneity from stochastic partitioning at cell division. Nat. Genet. 2011, 43:95-100.
70. Arkin A., et al. Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics 1998, 149:1633-1648.
71. Hooshangi S., et al. Ultrasensitivity and noise propagation in a synthetic transcriptional cascade. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3581-3586.
72. Samoilov M.S., et al. From fluctuations to phenotypes: the physiology of noise. Sci. STKE 2006, 2006:re17.
73. Ajo-Franklin C.M., et al. Rational design of memory in eukaryotic cells. Genes Dev. 2007, 21:2271-2276.
74. St-Pierre F., Endy D. Determination of cell fate selection during phage lambda infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20705-20710.
75. Snijder B., et al. Population context determines cell-to-cell variability in endocytosis and virus infection. Nature 2009, 461:520-523.
76. Snijder B., Pelkmans L. Origins of regulated cell-to-cell variability. Nat. Rev. Mol. Cell Biol. 2011, 12:119-125.
77. Chubb J.R., Liverpool T.B. Bursts and pulses: insights from single cell studies into transcriptional mechanisms. Curr. Opin. Genet. Dev. 2010, 20:478-484.
78. Blake W.J., et al. Noise in eukaryotic gene expression. Nature 2003, 422:633-637.
79. Huang S., Ingber D.E. A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis. 2006, 26:27-54.
80. Brock A., et al. Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. Genet. 2009, 10:336-342.